MEDICINAL ORGANIC CHEMISTRY GROUP

Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs

Source of Funding: Fundação para a Ciência e a Tecnologia (FCT)

Period: 2025-2027

Link: https://medorgchemlab.wixsite.com/protac4oncop53

​

HORIZON-TMA-MSCA-DN

Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment

Source of Funding: European Commission

Period: 2022-2026

Link: https://cordis.europa.eu/project/id/101073231

 

COST ACTION

European COST Action CA21145 “European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (EURESTOP)”

Source of Funding: European Cooperation in Science and Technology (COST) actions

Period: 2022-2026​​

Link: https://eurestop.eu/